Vergoeding 2020-2024 voor ATC-subgroep L04AG08 : Ocrelizumab
- Raming voor de totale Zvw-populatie
| 2020 | 2021 | 2022 | 2023* | 2024* | |
|---|---|---|---|---|---|
|
L04AG08 Ocrelizumab
|
31.722.793 | 45.874.148 | 60.735.720 | 72.947.881 | 83.902.242 |
| Totaal | 31.722.793 | 45.874.148 | 60.735.720 | 72.947.881 | 83.902.242 |